Institutional investors purchased a net $155.8 thousand shares of MDCO during the quarter ended June 2017 and now own 128.87% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WESTFIELD CAPITAL MANAGEMENT CO.... Bought 1.8 Million shares of Medicines Co
PUTNAM INVESTMENT MANAGEMENT LLC Bought 839.6 Thousand shares of Medicines Co
IRIDIAN ASSET MANAGEMENT LLC Bought 655.1 Thousand shares of Medicines Co